Company intelligence / Profile preview

BioNew Management

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

BioNew Management is a specialized investment firm focused on the life sciences and healthcare sectors, primarily operating through its BioNew Capital arm. The firm invests in innovative biotechnology, medical device, and healthcare service companies, with a significant focus on the Chinese and global markets. BioNew Management leverages deep industry expertise to identify and support early-to-growth stage companies developing transformative medical technologies and therapies. Their portfolio typically includes companies working on oncology, immunology, and advanced diagnostic platforms.

Industry: Investors

Beyond the preview

Go deeper on BioNew Management.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioNew Management.

Explore the full profile